[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
September 17, 1997

Bioequivalence of Levothyroxine Preparations: Issues of Science, Publication, and Advertising-Reply

Author Affiliations

Senior Editor, JAMA
Deputy Editor, JAMA
Publisher, JAMA

JAMA. 1997;278(11):899-900. doi:10.1001/jama.1997.03550110037029

In Reply.  —Dr Lankin and Mr Birnbaum raise concerns regarding the appearance of advertisements for levothyroxine from Jones Medical Industries in the same issue as the study by Dong et al and raise questions about the policies and procedures of The Journal with respect to the relationship between editorial and advertising content and functions.The AMA publications follow specific principles governing advertising,1 which include eligibility requirements, specific policies for pharmaceutical advertising, guidelines for price comparison advertising, and standards for advertising copy. The scientific journals, the editorial staff, and the advertising sales force also adhere to the standards for advertisements set forth by the International Committee of Medical Journal Editors,2 which stipulate that advertising must not influence editorial decisions, juxtaposition of editorial and advertising material on the same product or subject is avoided, and advertising is not sold on the condition that it will appear in the same issue as a